Showing 1 - 15 results of 15 for search 'N. I. Sultanbaeva', query time: 0.04s
Refine Results
-
1
Clinical case of the treatment of metastatic luminal breast cancer by A. F. Nasretdinov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, A. A. Izmailov, R. T. Ayupov
Published 2021-12-01
Article -
2
Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer by A. F. Nasretdinov, N. I. Sultanbaeva, Sh. I. Musin, A. V. Pushkarev, K. V. Menshikov, V. A. Pushkarev, A. V. Sultanbaev
Published 2020-06-01
Article -
3
Neuroendocrine Tumours: a Literature Review by K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, I. A. Menshikova, A. F. Nasretdinov, N. I. Sultanbaeva, I. R. Shaykhutdinov
Published 2021-05-01
Article -
4
-
5
-
6
-
7
-
8
-
9
-
10
Efficacy of the 1<sup>st</sup> generation tyrosine kinase inhibitor sunitinib in the treatment of metastatic renal cell carcinoma in alternative dosing regimens by K. V. Menshikov, A. V. Sultanbaev, Sh. I. Musin, A. A. Izmailov, V. S. Chalov, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, D. O. Lipatov
Published 2022-06-01
Article -
11
-
12
Inhibitors of cyclin-dependent kinases 4/6 for breast cancer patients with different somatic mutations of the PIK3CA gene by A. F. Nasretdinov, N. I. Sultanbaeva, Sh. I. Musin, O. N. Lipatov, A. A. Izmailov, R. T. Ayupov, K. V. Menshikov, A. V. Pushkarev, A. V. Sultanbaev
Published 2020-12-01
Article -
13
-
14
-
15
Multilineal treatment strategy of HER2-positive metastatic breast cancer (clinical case) by A. F. Nasretdinov, A. V. Pushkarev, O. N. Lipatov, N. I. Sultanbaeva, Sh. I. Musin, K. V. Menshikov, A. A. Izmailov, V. A. Pushkarev, M. G. Galeev, R. R. Muginov, R. B. Valiakhmedov, D. D. Sakaeva, A. V. Sultanbaev
Published 2021-06-01
Article